Funder: National Institutes of Health
Due Date: January 17, 2018
This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative established to accelerate cancer research. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): the Implementation of Integrated and Evidenced-based Symptom Management Throughout the Cancer Trajectory. The purpose of this specific FOA is to promote research on the implementation and evaluation of comprehensive symptom management systems for use in cancer care delivery through a Research Consortium. This research will provide new insights and valuable evidence that can be used to guide efforts on a nation-wide basis to improve symptom control for cancer patients during treatment and survivorship.
The consortium will consist of a Coordinating Center (to be supported by this U24 FOA) and Research Centers (to be funded under a companion UM1 FOA, RFA-CA-17-042).
The Coordinating Center is expected to:
(1) Provide oversight and coordination of the Research Centers and the Steering Committee,
(2) Ensure standardized, harmonized data collection across the Research Centers,
(3) Establish processes for pooled analyses.
The Coordinating Center is expected to interact with the Research Centers and provide oversight and management of collaborative activities within the entire consortium. Collaborative activities will be supported scientifically and coordinated administratively and logistically by the Coordinating Center.
Research Centers are responsible for the deployment and evaluation of the symptom assessment and management system using implementation science approaches.